Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

4,026 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Abnormal fucosylation of alpha-fetoprotein in patients with nonalcoholic steatohepatitis.
Nouso K, Furubayashi Y, Kariyama K, Wakuta A, Miyake N, Inoue K, Nagai Y, Murakami S, Adachi T, Oyama A, Wada N, Takeuchi Y, Sakata M, Yasunaka T, Onishi H, Shiraha H, Takaki A, Shiota S, Yasuda S, Toyoda H, Kawanaka M, Kumada T, Okada H. Nouso K, et al. Among authors: takeuchi y. Hepatol Res. 2021 May;51(5):548-553. doi: 10.1111/hepr.13626. Epub 2021 Mar 19. Hepatol Res. 2021. PMID: 33596344
Clinical characteristics of drug-induced liver injury in the elderly.
Onji M, Fujioka S, Takeuchi Y, Takaki T, Osawa T, Yamamoto K, Itoshima T. Onji M, et al. Among authors: takeuchi y. Hepatol Res. 2009 Jun;39(6):546-52. doi: 10.1111/j.1872-034X.2009.00492.x. Epub 2009 Feb 25. Hepatol Res. 2009. PMID: 19254343
Hepatitis B e antigen predicts delayed reduction of HBV DNA without viral breakthrough with adefovir dipivoxil and lamivudine: a 5-year study of patients with hepatitis B with lamivudine resistance.
Ikeda F, Baba N, Takaguchi K, Kubota J, Miyoshi K, Fujioka S, Moritou Y, Takeuchi Y, Yasunaka T, Miyake Y, Takaki A, Iwasaki Y, Kobashi H, Yamamoto K. Ikeda F, et al. Among authors: takeuchi y. J Med Virol. 2012 Oct;84(10):1562-70. doi: 10.1002/jmv.23371. J Med Virol. 2012. PMID: 22930504
Evaluation of the effect of sorafenib using serum NX-des-γ-carboxyprothrombin in patients with hepatocellular carcinoma.
Miyahara K, Nouso K, Morimoto Y, Tomoda T, Kobayashi S, Takeuchi Y, Hagihara H, Kuwaki K, Ohnishi H, Ikeda F, Miyake Y, Nakamura S, Shiraha H, Takaki A, Yamamoto K; Okayama Liver Cancer Group. Miyahara K, et al. Among authors: takeuchi y. Hepatol Res. 2013 Oct;43(10):1064-70. doi: 10.1111/hepr.12055. Epub 2013 Jan 25. Hepatol Res. 2013. PMID: 23347420
Efficacy of sorafenib beyond first progression in patients with metastatic hepatocellular carcinoma.
Miyahara K, Nouso K, Morimoto Y, Takeuchi Y, Hagihara H, Kuwaki K, Onishi H, Ikeda F, Miyake Y, Nakamura S, Shiraha H, Takaki A, Iwadou S, Kobayashi Y, Takaguchi K, Takuma Y, Takabatake H, Sakaguchi K, Yamamoto K; Okayama Liver Cancer Group. Miyahara K, et al. Among authors: takeuchi y. Hepatol Res. 2014 Mar;44(3):296-301. doi: 10.1111/hepr.12123. Epub 2013 Apr 29. Hepatol Res. 2014. PMID: 23607549
Predictive impact of polymorphism of PNPLA3 on HCC development after interferon therapy in Japanese patients with chronic hepatitis C.
Moritou Y, Ikeda F, Iwasaki Y, Baba N, Takaguchi K, Senoh T, Nagano T, Takeuchi Y, Yasunaka T, Ohnishi H, Miyake Y, Takaki A, Nouso K, Yamamoto K. Moritou Y, et al. Among authors: takeuchi y. Springerplus. 2013 Jun 1;2(1):251. doi: 10.1186/2193-1801-2-251. Print 2013 Dec. Springerplus. 2013. PMID: 23772356 Free PMC article.
4,026 results